Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 26.10.2026 5 Ann Neurol 2 Exp Neurol 1 J Neural Transm (Vienna) 1 J Neuropsychol 7 Mov Disord 1 Nat Neurosci 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. LUO L, Schaper FLWVJ, Nguyen M, Garimella AH, et al
   A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation.
   Ann Neurol. 2026 Aug 6. doi: 10.1002/ana.78320.
   PubMed         Abstract available
   
   
2. SIDEROWF A, Heathers LEA, Fabrizio K, Kuhl MM, et al
   Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.
   Ann Neurol. 2026;100 Suppl 38:S17-S25.
   PubMed         Abstract available
   
   
3. TANNER CM, Stanley CE, Brown EG, Chahine LM, et al
   Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.
   Ann Neurol. 2026;100 Suppl 38:S80-S87.
   PubMed         Abstract available
   
   
4. SIMUNI T, Coffey CS, Kopil CM, Allen-Savietta C, et al
   How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.
   Ann Neurol. 2026;100 Suppl 38:S97-S105.
   PubMed         Abstract available
   
   
5. FOROUD T, Heathers LEA, Bukhari S, Poston KL, et al
   Insights Gained From the PPMI Brain Donation Program.
   Ann Neurol. 2026;100 Suppl 38:S63-S71.
   PubMed         Abstract available
   
   

   
   Exp Neurol

6. LIU X, Min X, Zhang Z, Du Z, et al
   Tristetraprolin attenuates microglial neuroinflammation via post-transcriptional destabilization of TRAF6 mRNA in Parkinson's disease.
   Exp Neurol. 2026 Oct 21:116079. doi: 10.1016/j.expneurol.2026.116079.
   PubMed         Abstract available
   
   
7. KHAN A, Jawaid T, Rehman ZU, Alshammari MK, et al
   A critical mechanistic synthesis of PINK1-mediated mitophagy signaling and its therapeutic targeting in Parkinson's disease neurodegeneration.
   Exp Neurol. 2026;408:116078.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

8. CHEREAU V, Underwood BR
   What can clinical disorders involving the basal ganglia tell us about the pathophysiology of obsessive and compulsive symptoms?
   J Neural Transm (Vienna). 2026;133:2103-2120.
   PubMed         Abstract available
   
   

   
   J Neuropsychol

9. POLIAKOFF E, Hall A, Edmonds E, Baimbridge P, et al
   Experience in action: Using art-science activities to explore experiences of movement and the body in Parkinson's and autism.
   J Neuropsychol. 2026 Oct 17. doi: 10.1111/jnp.70085.
   PubMed         Abstract available
   
   

   
   Mov Disord

10. GLASER AC, Chua MMJ, Mazurek M, Meyer G, et al
    Repeat Ipsilateral Focused Ultrasound Thalamotomy after Tremor Recurrence: Safety, Efficacy, and Lesion Analysis.
    Mov Disord. 2026;41:2668-2676.
    PubMed         Abstract available
    
    
11. GARCIA-DIAZ S, Martin-Rodriguez JF, Munoz-Delgado L, Diaz-Belloso R, et al
    Cross-Cohort Evidence Links KCNJ6 rs702859 to Impulsive-Compulsive Phenotypes in Parkinson's Disease.
    Mov Disord. 2026 Oct 21. doi: 10.1002/mds.70586.
    PubMed         Abstract available
    
    
12. ALBERS C, Avanzino L, de Lange E, Botta A, et al
    Determinants of Cueing Responsiveness in Parkinson's Disease: Insights from the UNITE-PD Study.
    Mov Disord. 2026 Oct 21. doi: 10.1002/mds.70567.
    PubMed         Abstract available
    
    
13. SLATER NM, Myall DJ, Shoorangiz R, Meissner WG, et al
    Cortical Cholinergic Pathway Degeneration Reflects Cognitive Impairment and Dementia in Parkinson's Disease.
    Mov Disord. 2026 Oct 19. doi: 10.1002/mds.70584.
    PubMed         Abstract available
    
    
14. ZHAO CW, Robbins N, Krolewski R, Liu J, et al
    Pre-Diagnostic Factors Associated with Coding-Based Incident Multiple System Atrophy: A Nested Case-Control Study of the UK Biobank.
    Mov Disord. 2026;41:2615-2627.
    PubMed         Abstract available
    
    
15. CHATTREE G, Chrapkiewicz R, Zhang Y, Li J, et al
    Amantadine Modulates Action-Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions.
    Mov Disord. 2026;41:2723-2736.
    PubMed         Abstract available
    
    
16. MILLAR VERNETTI P, Palma JA, Biaggioni I, Shibao CA, et al
    Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure.
    Mov Disord. 2026;41:2638-2649.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

17. MA FX, Zhao XX, Wang XX, Fang SY, et al
    Dysregulated cholesterol trafficking through ABCA1 drives neurodegeneration in Parkinson's disease.
    Nat Neurosci. 2026 Oct 20. doi: 10.1038/s41593-026-02487.
    PubMed         Abstract available
    
    

    
    PLoS One

18. 
    Retraction: Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
    PLoS One. 2026;21:e0360896.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum